Hinge Health financials
$95.21+2.99%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 |
|---|---|---|---|---|---|
| Revenue | $212.8M | $182.3M | $170.7M | $154.2M | $139.1M |
| Gross profit | $183.9M | $154.2M | $144.0M | $126.2M | $97.8M |
| Gross margin | 86.4% | 84.6% | 84.4% | 81.8% | 70.3% |
| Operating income | $40.4M | $32.1M | $27.3M | -$6.1M | -$580.7M |
| Net income | $43.1M | $34.0M | $32.1M | -$1.8M | -$575.7M |
| Net margin | 20.3% | 18.7% | 18.8% | −1.2% | −413.8% |
| Diluted EPS | $0.52 | $0.41 | — | $-0.02 | $-13.10 |
| EBITDA | $41.5M | $33.2M | $28.5M | -$4.8M | -$579.3M |
| Operating cash flow | $101.4M | $43.1M | $63.9M | $82.4M | $20.2M |
| Free cash flow | $101.3M | $43.0M | $61.5M | $81.3M | $20.0M |
| Diluted shares | 83.4M | 82.4M | — | 78.9M | 43.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 |
|---|---|---|---|---|---|
| Cash & equivalents | $286.2M | $186.7M | $208.0M | $261.3M | $237.2M |
| Short-term investments | $103.2M | $129.2M | $155.9M | $218.7M | $176.1M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $827.4M | $728.8M | $744.8M | $769.8M | $693.7M |
| Total liabilities | $483.1M | $417.2M | $366.2M | $361.9M | $320.0M |
| Shareholders' equity | $344.3M | $111.7M | $178.7M | $208.0M | $173.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology